Rehabilitation Research Laboratory 2rLab, Department of Business Economics, Health and Social Care, University of Applied Sciences and Arts of Southern Switzerland, Via Violino 11, Manno 6928, Switzerland.
Rehazentrum, Taminaplatz 1, Valens 7317, Switzerland.
Mult Scler Relat Disord. 2019 Oct;35:26-33. doi: 10.1016/j.msard.2019.06.034. Epub 2019 Jun 29.
Multiple sclerosis (MS)-related fatigue limits participation in everyday activities and has a considerable impact on quality of life (QoL), thereby affecting productivity and employment. Outpatient education interventions involving energy conservation strategies and cognitive behavioral therapy techniques are helpful. However, no inpatient program is currently available. The inpatient energy management education (IEME) program is a novel group-based intervention that lasts for 6.5 h and is conducted by a trained occupational therapist (OT) during a 3-week period of inpatient rehabilitation. Persons with MS (pwMS) and OTs previously evaluated the IEME positively in a pilot study test run. The aim of this study was to evaluate the feasibility of a research protocol and collect preliminary data on the IEME effect size.
To assess the feasibility of conducting a randomized clinical trial, pwMS-related fatigue were recruited during a 3-week inpatient rehabilitation. Six IEME (experimental) group sessions or progressive muscle relaxation (PMR, control) group sessions comprised part of a personalized rehabilitation program. The recruitment and assessment procedures, dropout and follow-up assessment rates and the treatment fidelity were evaluated, and six telephone interviews were conducted with IEME participants after they returned home. Outcomes were fatigue impact, occupational performance, self-efficacy regarding energy conservation strategies, and QoL at baseline, discharge, and 4 months. Paired-sample and independent-samples t-tests were used to assess within- and between-group effects. Effect sizes were estimated using Cohen's d.
Between August and November 2017, 47 pwMS were included and randomized. The dropout rate (4.2%) was low and the sample was balanced. The PMR was a well-accepted control intervention. The OTs reported no problems in conducting the IEME, and treatment fidelity was high. IEME participants confirmed the adequacy of the IEME. Within-group differences in fatigue impact and some QoL dimensions at discharge were significant (p < 0.05) in both groups. The IEME alone resulted in significant improvements in self-efficacy regarding energy conservation strategies, with a large effect size (Cohen's d: 1.32; 95% CI: 0.54-2.1), and in the QoL physical functioning dimension at T2 (Cohen's d: 1.32; 95% CI: 2.11-0.53). IEME participants spent significantly less time in individual OT sessions. A sample size of 192 participants in a randomized controlled trial would be sufficient to detect clinically relevant between-group differences.
This feasibility study has provided promising preliminary data about the effect of the IEME. The research protocol was confirmed to be feasible and a future study is justified. This study was registered in the German Clinical Trials Register (no. DRKS00011634).
多发性硬化症(MS)相关的疲劳限制了患者参与日常活动的能力,并对生活质量(QoL)产生了重大影响,从而影响了生产力和就业。涉及能量保存策略和认知行为疗法技术的门诊教育干预措施是有帮助的。然而,目前没有住院计划。住院能量管理教育(IEME)计划是一种新的基于小组的干预措施,持续 6.5 小时,由经过培训的作业治疗师(OT)在住院康复的 3 周期间进行。多发性硬化症患者(pwMS)和 OT 此前在试点研究中对 IEME 进行了积极评估。本研究的目的是评估一项研究方案的可行性,并收集 IEME 效果大小的初步数据。
为了评估进行随机临床试验的可行性,在 3 周的住院康复期间招募了与多发性硬化症相关的疲劳患者。六个 IEME(实验组)或渐进性肌肉松弛(PMR,对照组)小组会议构成了个性化康复计划的一部分。评估了招募和评估程序、辍学和随访评估率以及治疗的保真度,并在 IEME 参与者回家后进行了六次电话访谈。在基线、出院和 4 个月时评估疲劳影响、职业表现、能量保存策略自我效能和生活质量。使用配对样本和独立样本 t 检验评估组内和组间效应。使用 Cohen 的 d 估计效应大小。
2017 年 8 月至 11 月,纳入并随机分配了 47 名 pwMS。辍学率(4.2%)较低,样本均衡。PMR 是一种被广泛接受的对照干预措施。OT 报告说在进行 IEME 时没有遇到问题,治疗的保真度很高。IEME 参与者证实了 IEME 的充分性。在两组中,疲劳影响和一些生活质量维度在出院时的组内差异均具有统计学意义(p<0.05)。IEME 单独使用可显著提高能量保存策略的自我效能,效果大小较大(Cohen 的 d:1.32;95%CI:0.54-2.1),并且在 T2 时 QoL 身体功能维度也有显著改善(Cohen 的 d:1.32;95%CI:2.11-0.53)。IEME 参与者在个体 OT 会议上花费的时间明显减少。在随机对照试验中,192 名参与者的样本量足以检测到具有临床意义的组间差异。
这项可行性研究提供了关于 IEME 效果的有希望的初步数据。研究方案被证实是可行的,有理由进行进一步的研究。本研究已在德国临床试验注册处(DRKS00011634)注册。